GenomePrecision

About:

GenomePrecision is a national economic and technological development zone.

Website: http://www.genomeprecision.com/

Top Investors: Oriental Fortune Capital, Sunland Fund, China Growth Capital | CGC, Med-Fine Capital, Grand Yangtze Capital

Description:

Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.

Total Funding Amount:

300M CNY

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2015-01-01

Founders:

Ye Feng

Number of Employees:

251-500

Last Funding Date:

2021-04-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai